SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease.
EuroPCR 2011 research highlights: A slideshow presentation
Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer The NOBORI.
Speaker’s name: George Dangas I have the following potential conflicts of interest to report: Research contracts x Consulting (speaker honoraria –
BURZOTTA F. 1, PAN M. 2 (CO-FIRST AUTHOR), TRANI C. 1, MEDINA A. 3, SUÀREZ DE LEZO J. 2, NICCOLI G. 1, ROMERO M. 2, PORTO I. 1, MAZUELOS F. 2, LEONE A.M.
SEA-CORP BC : SEA side and COR pal B ifurcation trials C ooperative study
